173 related articles for article (PubMed ID: 23095717)
1. Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables.
Guan X; Zhang N; Yin Y; Kong B; Yang Q; Han Z; Yang X
J Exp Clin Cancer Res; 2012 Oct; 31(1):89. PubMed ID: 23095717
[TBL] [Abstract][Full Text] [Related]
2. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
[TBL] [Abstract][Full Text] [Related]
3. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
[TBL] [Abstract][Full Text] [Related]
4. p73 G4C14-to-A4T14 polymorphisms are positively correlated with triple-negative breast cancer in southwestern China.
Zhou X
Med Oncol; 2013 Jun; 30(2):515. PubMed ID: 23443851
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.
Umar M; Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1153-62. PubMed ID: 21573788
[TBL] [Abstract][Full Text] [Related]
6. Regulation of female reproduction by p53 and its family members.
Feng Z; Zhang C; Kang HJ; Sun Y; Wang H; Naqvi A; Frank AK; Rosenwaks Z; Murphy ME; Levine AJ; Hu W
FASEB J; 2011 Jul; 25(7):2245-55. PubMed ID: 21402718
[TBL] [Abstract][Full Text] [Related]
7. [p73 polymorphisms and clinicopathologic characteristics in breast cancer].
Zhou X; Wu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):238-43. PubMed ID: 22561492
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
Misra C; Majumder M; Bajaj S; Ghosh S; Roy B; Roychoudhury S
Mol Carcinog; 2009 Sep; 48(9):790-800. PubMed ID: 19204927
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
10. [Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].
Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Zhang XR; Sun Y; Xu BH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):107-10. PubMed ID: 16750013
[TBL] [Abstract][Full Text] [Related]
11. Association between the p73 G4C14-to-A4T14 polymorphism and risk of nasopharyngeal carcinoma: a case-control and family-based study.
Zhang X; Cao P; Zhai Y; Zhang H; Cui Y; Wu Z; Yuan X; Wang Z; Li P; Yu L; Xia X; He F; Zhou G
Carcinogenesis; 2014 Sep; 35(9):1977-82. PubMed ID: 24590897
[TBL] [Abstract][Full Text] [Related]
12. The TP73 gene polymorphism (rs4648551, A>G) is associated with diminished ovarian reserve.
Vagnini LD; Renzi A; Oliveira-Pelegrin GR; Canas Mdo C; Petersen CG; Mauri AL; Oliveira JB; Baruffi RL; Cavagna M; Franco Junior JG
PLoS One; 2015; 10(3):e0120048. PubMed ID: 25794170
[TBL] [Abstract][Full Text] [Related]
13. Association study between P53 and P73 gene polymorphisms and the sporadic late-onset form of Alzheimer's disease.
Scacchi R; Gambina G; Moretto G; Corbo RM
J Neural Transm (Vienna); 2009 Sep; 116(9):1179-84. PubMed ID: 19657586
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
15. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.
Arfaoui AT; Kriaa LB; El Hadj Oel A; Ben Hmida MA; Khiari M; Khalfallah T; Gharbi L; Mzabi S; Bouraoui S
Virchows Arch; 2010 Sep; 457(3):359-68. PubMed ID: 20644956
[TBL] [Abstract][Full Text] [Related]
16. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.
De Feo E; Simone B; Kamgaing RS; Gallì P; Hamajima N; Hu Z; Li G; Li Y; Matsuo K; Park JY; Roychoudhury S; Spitz MR; Wei Q; Zhang JH; Ricciardi W; Boccia S
Mutagenesis; 2012 May; 27(3):267-73. PubMed ID: 21976716
[TBL] [Abstract][Full Text] [Related]
17. P53, p21, and p73 gene polymorphisms in gastric carcinoma.
Shirai O; Ohmiya N; Taguchi A; Nakamura M; Kawashima H; Miyahara R; Itoh A; Hirooka Y; Watanabe O; Ando T; Goto Y; Hamajima N; Goto H
Hepatogastroenterology; 2010; 57(104):1595-601. PubMed ID: 21443127
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.
Wang L; Gao R; Yu L
Mol Biol Rep; 2012 Feb; 39(2):1731-8. PubMed ID: 21617940
[TBL] [Abstract][Full Text] [Related]
19. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.
Gallì P; Cadoni G; Volante M; De Feo E; Amore R; Giorgio A; Arzani D; Paludetti G; Ricciardi G; Boccia S
BMC Cancer; 2009 May; 9():137. PubMed ID: 19426493
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of the p53 and p73 polymorphisms on lung cancer risk.
Schabath MB; Wu X; Wei Q; Li G; Gu J; Spitz MR
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):158-61. PubMed ID: 16434604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
